Bausch Health Companies Inc (BHC) concluded trading on Thursday at a closing price of $7.55, with 9.06 million shares of worth about $68.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.15% during that period and on July 11, 2024 the price saw a gain of about 3.14%. Currently the company’s common shares owned by public are about 365.24M shares, out of which, 357.55M shares are available for trading.
Stock saw a price change of 5.59% in past 5 days and over the past one month there was a price change of 19.46%. Year-to-date (YTD), BHC shares are showing a performance of -5.86% which decreased to -12.72% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.05 but also hit the highest price of $11.46 during that period. The average intraday trading volume for Bausch Health Companies Inc shares is 2.90 million. The stock is currently trading 11.04% above its 20-day simple moving average (SMA20), while that difference is up 9.68% for SMA50 and it goes to -3.74% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bausch Health Companies Inc (NYSE: BHC) currently have 365.24M outstanding shares and institutions hold larger chunk of about 77.98% of that.
The stock has a current market capitalization of $2.77B and its 3Y-monthly beta is at 0.77. It has posted earnings per share of -$1.24 in the same period. It has Quick Ratio of 0.85. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BHC, volatility over the week remained 3.55% while standing at 3.38% over the month.
Stock’s fiscal year EPS is expected to rise by 3.63% while it is estimated to increase by 16.38% in next year. EPS is likely to shrink at an annualized rate of 2.60% for next 5-years, compared to annual growth of 32.76% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Raymond James on July 10, 2024 offering a Mkt perform rating for the stock and assigned a target price of $8 to it. Coverage by Jefferies stated Bausch Health Companies Inc (BHC) stock as a Buy in their note to investors on September 20, 2023, suggesting a price target of $16 for the stock. Stock get a Sector perform rating from RBC Capital Mkts on July 29, 2022.
